Oxygenta Pharmaceutical Ltd - OXYGENTA PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE102E01018

Oxygenta Pharmaceutical Ltd KEY RATIOS

No Record Found

Oxygenta Pharmaceutical Ltd Corporate Actions

29 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

26 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Feb , 2023

12:00 AM

22 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Feb , 2023

12:00 AM

03 Nov , 2022

12:00 AM

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Sep , 2022

12:00 AM

AGM

Announcement date: 21 Sep , 2022

View Details

03 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Aug , 2022

12:00 AM


Oxygenta Pharmaceutical Ltd SHAREHOLDING SNAPSHOT
29 May , 2023 | 06:51 AM

PROMOTER - TOTAL8.99%

Indian: 8.99%

Foreign: 0%

NON-PROMOTER - TOTAL 91.01%

Institutions: 0.07%

Non-Institutions: 90.94%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Oxygenta Pharmaceutical Ltd News and Update

Image not found
  • 23 May, 2023 |
  • 5:30 PM

NTPC is also planning to come up with initial public offering for its renewable energy arm NTPC Green Energy Ltd (NGEL) to raise funds

Article Image
Image not found
  • IIFL News Service |
  • 22 May, 2023 |
  • 5:28 PM
Image not found
  • IIFL News Service |
  • 05 May, 2023 |
  • 5:04 PM
ad IconAd Image

Oxygenta Pharmaceutical Ltd FINANCIALS

No Data Available To Display Chart

Oxygenta Pharmaceutical Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Oxygenta Pharmaceutical Ltd

  • N Gangi Reddy
  • Independent Director
  • Sai Sudhakar Vankineni
  • Managing Director
  • D Vidya Sagar
  • Independent Director
  • Krishna Reddy
  • Director (Operation)
  • Muralidhar R
  • Director (Technical)
  • Sangari Kondal Reddy
  • Independent Director
  • Padmaja Surapureddy
  • Independent Director
  • Kanuganti Raghavender Rao
  • Executive Director
  • Veerendra Babu R
  • Company Sec. & Compli. Officer

Summary

Summary Info Not Found


Reports by Oxygenta Pharmaceutical Ltd


Reports by Oxygenta Pharmaceutical Ltd